You just read:

MDA Awards $750,000 to Help Summit Test New Drug Formulation in Phase 1 Clinical Trial of Potential Treatment for Duchenne Muscular Dystrophy

News provided by

Muscular Dystrophy Association

Dec 19, 2011, 12:22 ET